Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular α-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogen

BMB Reports

Volumn 47, Issue 12, 2014, Pages 691-696

  Kim, Yong Tae ^a   Kim, Se kwon ^b   Jeon, You Jin ^c   Park, Sun Joo ^b  

^a Kunsan National University   (South Korea)

^b Pukyong National University   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

Invasion; Plasminogen; Seahorse peptide; enolase

Indexed keywords

ENOLASE; IMMOBILIZED ENZYME; PEPTIDE; PLASMINOGEN; PROTEIN BINDING; SMALL INTERFERING RNA; UROKINASE;

AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHEMISTRY; DRUG EFFECTS; ENZYME ACTIVATION; FIBROSARCOMA; GENETICS; HUMAN; IMMUNOPRECIPITATION; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SMEGMAMORPHA; SYNTHESIS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; ENZYMES, IMMOBILIZED; FIBROSARCOMA; HUMANS; IMMUNOPRECIPITATION; PEPTIDES; PHOSPHOPYRUVATE HYDRATASE; PLASMINOGEN; PROTEIN BINDING; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMEGMAMORPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84922326128     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.12.235     Document Type: Article

References (20)

1. Takei, N., Kondo, J., Nagaike, K., Ohsawa, K., Kato, K. and Kohsaka, S. (1991) Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J. Neurochem. 57, 1178-1184.
2. Fluit, A. C., Wolfhagen, M. J., Jansze, M., Torensma, R. and Verhoef, J. (1993) Toxin B of Clostridium difficile does not have enolase activity. FEBS Lett. 316, 103-105.
3. al-Giery, A. G. and Brewer, J. M. (1992) Characterization of the interaction of yeast enolase with polynucleotides. Biochim. Biophys. Acta. 1159, 134-140.
4. Vanegas, G., Quinones, W., Carrasco-Lopez, C., Concepcion, J. L., Albericio, F. and Avilan, L. (2007) Enolase as a plasminogen binding protein in Leishmania mexicana. Parasitol. Res. 101, 1511-1516.
5. Mundodi, V., Kucknoor, A. S. and Alderete, J. F. (2008) Immunogenic and plasminogen-binding surface-associated alpha-enolase of Trichomonas vaginalis. Infect. Immun. 76, 523-531.
6. Plow, E. F., Felez, J. and Miles, L. A. (1991) Cellular regulation of fibrinolysis. Thromb. Haemost. 66, 32-36.
7. Plow, E. F., Herren, T., Redlitz, A., Miles, L. A. and Hoover-Plow, J. L. (1995) The cell biology of the plasminogen system. FASEB J. 9, 939-945.
8. Wiman, B. and Collen, D. (1979) On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin. J. Biol. Chem. 254, 9291-9297.
9. Lancefield, R. C. (1957) Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J. Exp. Med. 106, 525-544.
10. Gentile, F., Pizzimenti, S., Arcaro, A., Pettazzoni, P., Minelli, R., D'Angelo, D., Mamone, G., Ferranti, P., Toaldo, C., Cetrangolo, G., Formisano, S., Dianzani, M. U., Uchida, K., Dianzani, C. and Barrera, G. (2009) Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity. Biochem. J. 422, 285-294.
11. Ryu, B., Qian, Z. J. and Kim, S. K. (2010) Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-kappaB activation, and induces human osteoblastic and chondrocytic differentiation. Chem. Biol. Interact. 184, 413-422.
12. Quinones, W., Pena, P., Domingo-Sananes, M., Caceres, A., Michels, P. A., Avilan, L. and Concepcion, J. L. (2007) Leishmania mexicana: molecular cloning and characterization of enolase. Exp. Parasitol. 116, 241-251.
13. Pancholi, V. (2001) Multifunctional alpha-enolase: its role in diseases. Cell. Mol. Life Sci. 58, 902-920.
14. Boyle, M. D. and Lottenberg, R. (1997) Plasminogen activation by invasive human pathogens. Thromb. Haemost. 77, 1-10.
15. Coleman, J. L. and Benach, J. L. (1999) Use of the plasminogen activation system by microorganisms. J. Lab. Clin. Med. 134, 567-576.
16. Lahteenmaki, K., Edelman, S. and Korhonen, T. K. (2005) Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends. Microbiol. 13, 79-85.
17. Bergmann, S., Wild, D., Diekmann, O., Frank, R., Bracht, D., Chhatwal, G. S. and Hammerschmidt, S. (2003) Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol. Microbiol. 49, 411-423.
18. Ehinger, S., Schubert, W. D., Bergmann, S., Hammerschmidt, S. and Heinz, D. W. (2004) Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites. J. Mol. Biol. 343, 997-1005.
19. Felez, J., Chanquia, C. J., Levin, E. G., Miles, L. A. and Plow, E. F. (1991) Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood 78, 2318-2327.
20. Del Pozo, V., Rojo, M., Rubio, M. N., Cortegano, I., Cardaba, B., Gallardo, S., Ortega, M., Civantos, E., Lopez, E., Martin-Mosquero, C., Peces-Barba, G., Palomino, P., Gonzalez-Mangado, N. and Lahoz, C. (2002) Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through inerleukin-5 gene downregulation. Am. J. Respir. Crit. Care Med. 166, 732-737.